ArticleBlood2022

CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies.

Clara Bueno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.